Literature DB >> 2372828

Androgenetic mouse embryonic stem cells are pluripotent and cause skeletal defects in chimeras: implications for genetic imprinting.

J R Mann1, I Gadi, M L Harbison, S J Abbondanzo, C L Stewart.   

Abstract

The inviability of diploid androgenetic and parthenogenetic embryos suggests imprinting of paternal and maternal genes during germ cell development, and differential expression of loci depending on parental inheritance appears to be involved. To facilitate identification of imprinted genes, we have derived diploid androgenetic embryonic stem (ES) cell lines. In contrast to normal ES cells, they form tumors composed almost entirely of striated muscle when injected subcutaneously into adult mice. They also form chimeras following blastocyst injection, although many chimeras die at early postnatal stages. Surviving chimeras develop skeletal abnormalities, particularly in the rib cartilage. These results demonstrate that androgenetic ES cells are pluripotent and point to stage- and cell-specific expression of developmentally important imprinted genes.

Entities:  

Mesh:

Year:  1990        PMID: 2372828     DOI: 10.1016/0092-8674(90)90363-j

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  28 in total

1.  Epigenetic Interactions and Gene Expression in Peri-Implantation Mouse Embryo Development.

Authors:  Jean J Latimer; Roger A Pedersen
Journal:  Mod Cell Biol       Date:  1993

2.  Hematopoietic reconstitution with androgenetic and gynogenetic stem cells.

Authors:  Sigrid Eckardt; N Adrian Leu; Heath L Bradley; Hiromi Kato; Kevin D Bunting; K John McLaughlin
Journal:  Genes Dev       Date:  2007-02-15       Impact factor: 11.361

3.  Expression of insulin-like growth factor II (IGF)-II) and H19 in murine teratocarcinomas derived from embryonic stem (ES) cells.

Authors:  N L Blythe; P V Senior; F Beck
Journal:  J Anat       Date:  1996-02       Impact factor: 2.610

4.  In vivo and in vitro differentiation of uniparental embryonic stem cells into hematopoietic and neural cell types.

Authors:  Sigrid Eckardt; Timo C Dinger; Satoshi Kurosaka; N Adrian Leu; Albrecht M Müller; K John McLaughlin
Journal:  Organogenesis       Date:  2008-01       Impact factor: 2.500

5.  Harnessing the therapeutic potential of myogenic stem cells.

Authors:  Jason D White; Miranda D Grounds
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

6.  Autologous pluripotent stem cells generated from adult mouse testicular biopsy.

Authors:  Kinarm Ko; Guangming Wu; Marcos J Araúzo-Bravo; Julee Kim; Jury Francine; Boris Greber; Jörg Mühlisch; Jin Young Joo; Davood Sabour; Michael C Frühwald; Natalia Tapia; Hans R Schöler
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

7.  Quantitative proteomics analysis of parthenogenetically induced pluripotent stem cells.

Authors:  Zhe Hu; Lei Wang; Zhensheng Xie; Xinlei Zhang; Du Feng; Fang Wang; Bingfeng Zuo; Lingling Wang; Zhong Liu; Zhisheng Chen; Fuquan Yang; Lin Liu
Journal:  Protein Cell       Date:  2011-09-09       Impact factor: 14.870

8.  Distribution of androgenetic cells in fetal mouse chimeras.

Authors:  R Fundele; R Krause; S C Barton; M A Surani; B Christ
Journal:  Rouxs Arch Dev Biol       Date:  1995-08

Review 9.  Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.

Authors:  Teodora Ribarska; Klaus-Marius Bastian; Annemarie Koch; Wolfgang A Schulz
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

10.  Cell lines derived from human parthenogenetic embryos can display aberrant centriole distribution and altered expression levels of mitotic spindle check-point transcripts.

Authors:  Tiziana A L Brevini; Georgia Pennarossa; Stefania Antonini; Alessio Paffoni; Gianluca Tettamanti; Tiziana Montemurro; Enrico Radaelli; Lorenza Lazzari; Paolo Rebulla; Eugenio Scanziani; Magda de Eguileor; Nissim Benvenisty; Guido Ragni; Fulvio Gandolfi
Journal:  Stem Cell Rev Rep       Date:  2009-09-09       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.